NEW YORK (GenomeWeb News) – The US Department of Defense has awarded BioFire Diagnostics, formerly called Idaho Technology, a contract for up to $27.4 million.

In an announcement last week, the Defense Logistics Agency of DOD said the award is a modification on the second option year of a previously awarded contract and is a firm fixed-price, sole-source, indefinite delivery and indefinite quantity contract for reagents, extraction, and inhibition kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.